Sympathetic nervous system, diabetes, and hypertension
1Department of Internal Medicine, University of Turin, Torino, Italy. paolo.cavalloperin@unito.it
Diabetic patients have higher hypertension rates due to sympathetic nerve overactivity. This overactivity, linked to kidney issues or metabolic syndrome, increases cardiovascular risk, necessitating targeted treatments.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Hypertension is prevalent in diabetic individuals, occurring twice as often compared to the general population.
- Hypertension is more common in Type 2 diabetes, often preceding diagnosis, while in Type 1 diabetes, it's linked to nephropathy.
- Sympathetic nerve overactivity plays a key role in hypertension development in diabetes.
Purpose of the Study:
- To explore the role of sympathetic overactivity in hypertension pathogenesis in diabetic patients.
- To discuss the mechanisms linking sympathetic overactivity to hypertension in different diabetes types.
- To review therapeutic strategies for hypertension in diabetic subjects, considering their impact on sympathetic activity.
Main Methods:
- Review of existing literature on hypertension in diabetes.
- Analysis of the role of the renin-angiotensin-aldosterone system and insulin resistance.
- Examination of the impact of autonomic neuropathy and reduced nocturnal dipping.
Main Results:
- Sympathetic overactivity can stem from renin-angiotensin-aldosterone system activation in Type 1 diabetes with renal failure or insulin resistance in Type 2 diabetes with metabolic syndrome.
- Vagal impairment in autonomic neuropathy shifts sympatho-vagal balance, contributing to hypertension, often preceded by reduced nocturnal blood pressure dipping.
- Sympathetic overactivity increases cardiovascular risk through enhanced renin-angiotensin-aldosterone system activity, sodium reabsorption, and elevated heart rate, stroke volume, and vascular resistance.
Conclusions:
- Sympathetic overactivity is a critical factor in hypertension among diabetic patients, with distinct underlying mechanisms in Type 1 and Type 2 diabetes.
- Autonomic dysfunction, particularly vagal impairment, significantly contributes to hypertension and cardiovascular risk in diabetes.
- Pharmacological interventions targeting sympathetic activity are available, but their metabolic benefits remain debated.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
The Sympathetic Nervous System
Sympathetic Activation
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension II: Pathophysiology
Psychoneuroimmunology: Diabetes and Cancer
